ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2011
Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer.
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
59 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.Archives of pathology & laboratory medicine · 2014Guideline
- Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2018Trial
- MRI-based texture analysis for breast cancer subtype classification in a multi-ethnic population.Magma (New York, N.Y.) · 2026Article
- Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers.Breast cancer research : BCR · 2025Article
- Investigation of breast cancer molecular subtype in a multi-ethnic population using MRI.PloS one · 2024Article
- Article
- Narrative review of progress in pathological diagnosis of breast cancer.Translational breast cancer research : a journal focusing on translational research in breast cancer · 2022Review
- Mir-4728 is a Valuable Biomarker for Diagnostic and Prognostic Assessment of HER2-Positive Breast Cancer.Frontiers in molecular biosciences · 2022Article
- Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes.Cancers · 2021Article
- Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study.Annals of translational medicine · 2021Article
- Feasibility of Shear Wave Elastography Imaging for Evaluating the Biological Behavior of Breast Cancer.Frontiers in oncology · 2021Article
- Immunotyping of tumor-infiltrating lymphocytes in triple-negative breast cancer and genetic characterization.Oncology letters · 2020Article
- PIWI-Like 1 and PIWI-Like 2 Expression in Breast Cancer.Cancers · 2020Article
- Hormone receptor and HER2 assessment in breast carcinoma metastatic to bone: A comparison between FNA cell blocks and decalcified core needle biopsies.Cancer cytopathology · 2020Article
- Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.Cancer science · 2019Article
- Oestrogen receptor-negative/progesterone receptor-positive phenotype of invasive breast carcinoma in Japan: re-evaluated using immunohistochemical staining.Breast cancer (Tokyo, Japan) · 2019Article
- Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma.Virchows Archiv : an international journal of pathology · 2019Article
- US-guided Diffuse Optical Tomography: Clinicopathological Features Affect Total Hemoglobin Concentration in Breast Cancer.Translational oncology · 2018Article
- Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians.Geburtshilfe und Frauenheilkunde · 2018Article
- Differential expression and clinical significance of epithelial-mesenchymal transition markers among different histological types of triple-negative breast cancer.Journal of Cancer · 2018Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
21502545What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.